CORELATION USE OF HORMONAL CONTRACEPTION WITH INCIDENCE BREAST CANCER IN SURGERY POLICLINIC RSUD JOMBANG

Mudhawaroh Mudhawaroh, Septi Fitrah Ningtyas, Putu Arik Herliawati

Abstract


The number of cases of breast cancer in the world ranks second only to cervical cancer, breast cancer in addition to be one of the major killer of women in the world and the tendency of increase in cases in the world or in Indonesia. The purpose of this study was to determine the relationship between the use of hormonal contraception with the incidence of breast cancer in the surgical hospital poly Jombang.

This study uses a method of analysis with case control design. The case group was women with breast cancer in Poly Surgical Hospital Jombang and control group was women who did not have breast cancer in Poly Surgical Hospital Jombang, where each - each sample was 31 respondents. Odds Ratio value is calculated using a 2 x 2 table and the p-value using chi square test using SPSS. There were 31 respondents 31 respondents case and control groups in this study. Having calculated by multivariate logistic regression analysis showed that there was no significant association between the use of hormonal contraception with the incidence of breast cancer in Jombang Poly Surgical Hospital, which is characterized by the value of p = 0.276 and the value of OR = 8.523 Incompatibility results of this study with previous research or theory that there is possible to have several possibilities.

This can occur when women who use hormonal contraceptives maintain a healthy lifestyle, by maintaining the diet and activity by diligently exercising and minimizing the consumption of fatty foods, which in this study is supported by the nutritional status of women with breast cancer in part great rmempunyai normal nutritional status. However, if the user in the long term will also affect the incidence of breast cancer.


Keywords


Hormonal contraceptives, breast cancer

Full Text:

PDF

References


Mohammadbeigi A, Mohammadsalehi N, Valizadeh R, Momtaheni Z, Mokhtari M, Ansari H. Lifetime and 5 years risk of breast cancer and attributable risk factor according to Gail model in Iranian women. J Pharm Bioallied Sci. 2015;7(3):207.

Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer Targets Ther. 2019;11:151.

Coccia M. The effect of country wealth on incidence of breast cancer. Breast Cancer Res Treat. 2013;141(2):225–9.

Dzervite A, Pranka M, Lace T, Rungule R, Gardovskis J, Miklasevics E. Initial Findings of Breast Cancer Risk Factors from a Survey Conducted at Pauls Stradins Clinical University Hospital. Acta Chir Latv. 2013;13(1):34.

Ozsoy A, Barça N, Dolek BA, Aktaş H, Elverici E, Araz L, et al. The relationship between breast cancer and risk factors: a single-center study. Eur J breast Heal. 2017;13(3):145.

Veisy A, Lotfinejad S, Salehi K, Zhian F. Risk of breast cancer in relation to reproductive factors in North-West of Iran, 2013-2014. Asian Pacific J Cancer Prev. 2015;16(2):451–5.

Chen F, Bina WF. Correlation of white female breast cancer incidence trends with nitrogen dioxide emission levels and motor vehicle density patterns. Breast Cancer Res Treat. 2012;132(1):327–33.

Karim SM, Baeshen W, Neamatullah SN, Bin B. Oral contraceptives, abortion and breast cancer risk: a case control study in Saudi Arabia. Asian Pacific J Cancer Prev. 2015;16(9):3957–60.

Bardaweel SK, Akour AA, Al-Muhaissen S, AlSalamat HA, Ammar K. Oral contraceptive and breast cancer: do benefits outweigh the risks? A case–control study from Jordan. BMC Womens Health. 2019;19(1):1–7.

Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W, et al. Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Prev Biomarkers. 2010;19(10):2496–502.

Backman T, Rauramo I, Jaakkola K, Inki P, Vaahtera K, Launonen A, et al. Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol. 2005;106(4):813–7.

Fei X, Wu J, Kong Z, Christakos G. Urban-rural disparity of breast cancer and socioeconomic risk factors in China. PLoS One. 2015;10(2):e0117572.

Chagpar A, Coccia M. Breast cancer and socio-economic factors. 2012;

Rianti E, Tirtawati GA, Novita H. Faktor-faktor yang berhubungan dengan risiko kanker payudara wanita. J Heal Qual. 2012;

Al-Amri FA, Saeedi MY, Al-Tahan FM, Ali AM, Alomary SA, Arafa M, et al. Breast cancer correlates in a cohort of breast screening program participants in Riyadh, KSA. J Egypt Natl Canc Inst. 2015;27(2):77–82.

Keramatinia A, Hassanipour S, Nazarzadeh M, Wurtz M, Monfared AB, Khayyamzadeh M, et al. Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: a systematic review and meta-analysis. Asian Pacific J Cancer Prev. 2016;17(1):419–24.

Li L, Zhong Y, Zhang H, Yu H, Huang Y, Li Z, et al. Association between oral contraceptive use as a risk factor and triple-negative breast cancer: A systematic review and meta-analysis. Mol Clin Oncol. 2017;7(1):76–80.

Leonardi GC, Rapisarda V, Marconi A, Scalisi A, Catalano F, Proietti L, et al. Correlation of the risk of breast cancer and disruption of the circadian rhythm. Oncol Rep. 2012;28(2):418–28.

James FR, Wootton S, Jackson A, Wiseman M, Copson ER, Cutress RI. Obesity in breast cancer–what is the risk factor? Eur J Cancer. 2015;51(6):705–20.

Iatrakis G, Iavazzo C, Zervoudis S, Koumousidis A, Sofoudis C, Kalampokas T, et al. The role of oral contraception use in the occurrence of breast cancer. A retrospective study of 405 patients. Clin Exp Obstet Gynecol. 2021;38(3):225–7.

Suryanti Y. Fakto- Faktor Yang Berhubungan Dengan Penggunaan Metode Kontrasepsi Jangka Panjang Wanita Usia Subur. Jambura J Heal Sci Res. 2019;1(1):20–9.




DOI: https://doi.org/10.35971/jjhsr.v4i0.12567

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Creative Commons Licence
 

 

Jambura Journal of Health Sciences and Research is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

</p